Your browser doesn't support javascript.
Fasting Ramadan in patients with T1DM - Saudi Arabia versus other countries during the COVID-19 pandemic.
Alamoudi, Reem M; Aljohani, Naji J; Alfadhli, Eman M; Alzaman, Naweed; Alfadhly, Abdulaziz F; Kallash, Majd-Aldeen; Alshenqete, Abdulwadod M; Batais, Mohammed A; Alharbi, Mansour; Ekhzaimy, Aishah A; Sheshah, Eman; Ahmedani, Muhammad Yakoob; Buyukbese, Mehmet Akif; Shaltout, Inass; Hemaida, Kamel; Belkhadir, Jamal; Afandi, Bachar; Hafidh, Khadija; Hussein, Zanariah; Elbarbary, Nancy S; Hassanein, Mohamed.
  • Alamoudi RM; Department of Medicine, King Abdulaziz Medical City, King Abdullah International Research Centre, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guards Health Affairs, Jeddah, Saudi Arabia. Electronic address: amoudir@mngha.med.sa.
  • Aljohani NJ; Obesity, Endocrine and Metabolic Center, King Fahad Medical City, King Abdulaziz Bin Saud University for Health Sciences, Riyadh, Saudi Arabia.
  • Alfadhli EM; Department of Medicine, Medical College, Taibah University, AlMadinah, Saudi Arabia.
  • Alzaman N; Department of Medicine, Medical College, Taibah University, AlMadinah, Saudi Arabia.
  • Alfadhly AF; Department of Family Medicine, Prince Mansour Military Hospital, Taif City, Saudi Arabia.
  • Kallash MA; Obesity, Endocrine and Metabolic Center, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Alshenqete AM; Nutrition Department, King Fahd Hospital, AlMadina, Saudi Arabia.
  • Batais MA; Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alharbi M; Diabetes Centre, AlMadinah, Saudi Arabia.
  • Ekhzaimy AA; Department of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
  • Sheshah E; Diabetes Care Center, King Salman Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
  • Ahmedani MY; Department of Medicine, Baqai Institute of Diabetology & Endocrinology, Baqai Medical University, Karachi, Pakistan.
  • Buyukbese MA; Department of Internal Medicine, Medistate Kavacik Hospital, Istanbul, Turkey.
  • Shaltout I; Department of Internal Medicine and Diabetes, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hemaida K; Glan Clwyd Hospital, Renal and Diabetes, Rhyl, Denbighshire, UK; Alexandria University, Faculty of Medicine, Medical Department, Alexandria, Egypt.
  • Belkhadir J; Moroccan League for the Fight Against Diabetes, IDF Middle East and North Africa, Morocco.
  • Afandi B; Tawam Hospital, SEHA, Al Ain, United Arab Emirates.
  • Hafidh K; Diabetes Unit, Rashid Hospital, Dubai Health Authority, Dubai Academic Health Cooperation, United Arab Emirates.
  • Hussein Z; Department of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
  • Elbarbary NS; Department of Pediatrics, Ain Shams University, Cairo, Egypt.
  • Hassanein M; Department of Endocrinology and Diabetes, Dubai Hospital, Dubai Academic Health Cooperation, United Arab Emirates.
Diabetes Metab Syndr ; 17(1): 102676, 2022 Nov 22.
Article in English | MEDLINE | ID: covidwho-2238490
ABSTRACT
BACKGROUND AND

AIMS:

To compare Saudi Arabia with other countries regarding patient attitudes towards fasting Ramadan and complications related to fasting during the COVID-19 pandemic.

METHODS:

Data collected from Saudi Arabia and 12 other mostly Muslim majority countries, via physician administered questionnaire within post Ramadan 2020.

RESULTS:

1485 Type1 diabetes (T1DM) patients analyzed; 705 (47.5%) from Saudi Arabia vs. 780 (52.5%) from other countries. 1056 (71.1%) fasted Ramadan; 636 (90.2%) of Saudi patients vs. 420 (53.8%) of other countries. Experiencing Ramadan during the COVID-19 pandemic did not affect the Saudi T1DM patients' decision to fast while it significantly influenced their decision in other countries (1.4 vs 9.9%, P < 0.001). More Saudi patients needed to break the fast due to a diabetes related complication compared to other countries (67.4% vs. 46.8%, p=<0.001). The mean number of days fasted in Saudi and other countries was 24 ± 7 and 23 ± 8 days respectively. Hypoglycemic events were more common among Saudi patients during Ramadan compared to other countries 72% and 43.6% (p < 0.001) respectively. There was a significant difference in timing; the largest peak for Saudi Arabia patients was after dawn (35% vs 7%, p < 0.001), while it was pre-sunset for the other countries (23 vs 54%, p = 0.595). Day time-hyperglycemia was also more common among Saudi patients (48.6% vs. 39%, p < 0.001), however it was a less likely cause to break the fast (25.6% vs 38.3%, p < 0.001).

CONCLUSION:

Observing the fast of Ramadan is extremely common among Saudi T1DM patients compared to other Muslim countries and was not affected by the COVID-19 pandemic. However, it was associated with higher frequency of hypoglycemic and hyperglycemic episodes.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Diabetes Metab Syndr Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Journal: Diabetes Metab Syndr Year: 2022 Document Type: Article